SCHEMBL3462902

SCHEMBL3462902

CC(=O)OCC1(C)COC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.44
ALDH1A1 P00352 5/20 0.37
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ACACB O00763 1/20 0.35
PRKCA P17252 3/20 0.33
CYP19A1 P11511 1/20 0.33
ABCB1 P08183 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
G6PD P11413 1/20 0.33
TSHR P16473 2/20 0.31
CHRM5 P08912 2/20 0.31
CHRM1 P11229 2/20 0.31
CHRM3 P20309 2/20 0.31
PGR P06401 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
HTR1A P08908 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25130999 0.87 EPHX1 (0.38) EPHX1ALDH1A1LMNAHSD17B10ACACB
SCHEMBL12987206 0.84 EPHX1 (0.46) EPHX1ALDH1A1ACACBTSHRIRAK4
SCHEMBL13882267 0.83 ALDH1A1 (0.47) EPHX1ALDH1A1LMNAHSD17B10ACACB
SCHEMBL12987210 0.83 EPHX1 (0.44) EPHX1ACACBTSHRIRAK4
SCHEMBL25440118 0.81 EPHX1 (0.43) EPHX1ALDH1A1LMNAACACBPRKCA
SCHEMBL25440195 0.81 EPHX1 (0.43) EPHX1ACACBGAA
SCHEMBL16244250 0.81 EPHX1 (0.43) EPHX1LMNAHSD17B10ACACBGAA
SCHEMBL154821 0.80 ALDH1A1 (0.44) EPHX1ALDH1A1ACACBTSHR
SCHEMBL7272253 0.80 MGAM (0.40) EPHX1ACACBGAA
SCHEMBL2846730 0.80 ALDH1A1 (0.39) EPHX1ALDH1A1LMNAHSD17B10PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11737345-B2 Organic electronic material, ink composition containing same, and organic thin film, organic electronic element, organic electroluminescent element, lighting device, and display device formed therewith RESONAC CORPORATION (JP) 2023-08-22 US disclosed
US-20180145257-A1 ORGANIC ELECTRONIC MATERIAL, INK COMPOSITION CONTAINING SAME, AND ORGANIC THIN FILM, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELETROLUMINESCENT ELEMENT, LIGHTING DEVICE, AND DISPLAY DEVICE FORMED THEREWITH RESONAC CORPORATION (JP) 2018-05-24 US disclosed
US-9929346-B2 Organic electronic material, ink composition containing same, and organic thin film, organic electronic element, organic electroluminescent element, lighting device, and display device formed therewith HITACHI CHEMICAL COMPANY, LTD. (JP) 2018-03-27 US disclosed
US-9703193-B2 Onium salt, resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-07-11 US disclosed
US-9703193-B2 Onium salt, resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-07-11 US disclosed
US-20170073468-A1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS 2017-03-16 US disclosed
US-20170044308-A1 POLYMER OR OLIGOMER, HOLE TRANSPORT MATERIAL COMPOSITION, AND ORGANIC ELECTRONIC ELEMENT USING SAME HITACHI CHEMICAL COMPANY, LTD. (JP) 2017-02-16 US disclosed
US-20170044308-A1 POLYMER OR OLIGOMER, HOLE TRANSPORT MATERIAL COMPOSITION, AND ORGANIC ELECTRONIC ELEMENT USING SAME HITACHI CHEMICAL COMPANY, LTD. (JP) 2017-02-16 US disclosed
US-20160320698-A1 ONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-11-03 US disclosed
US-20160320698-A1 ONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-11-03 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070265180-A1 3-Methyl Oxetanemethanol Derivatives and Their Use in Perfume Compositions INTERNATION FLAVORS & FRAGRANCES INC. 2007-11-15 US disclosed
US-7265231-B2 3-methyl oxetanemethanol derivatives and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2007-09-04 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed
US-20060234882-A1 3-Methyl oxetanemethanol derivatives and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. 2006-10-19 US disclosed
EP-1712551-A1 3-Methyl oxetanemethanol derivatives and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) 2006-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 EPHX1 1428/4885ALDH1A1 617/4885LMNA 3030/4885
US-20070265180-A1 3-Methyl Oxetanemethanol Derivatives and Their Use in Perfume Compositions PNMT, CYP51A1, MSMO1 EPHX1 95/4885ALDH1A1 785/4885LMNA 3820/4885
US-20060234882-A1 3-Methyl oxetanemethanol derivatives and their use in perfume compositions PNMT, CYP51A1, MSMO1 EPHX1 95/4885ALDH1A1 785/4885LMNA 3820/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 EPHX1 1428/4885ALDH1A1 617/4885LMNA 3030/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 EPHX1 1428/4885ALDH1A1 617/4885LMNA 3030/4885
US-20160320698-A1 ONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS SLC6A5, EIF2B5, EIF2B4 EPHX1 2378/4885ALDH1A1 3739/4885LMNA 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.